Exhibit 99.1
Company Contact: | Investor Contact: | Agency Contact: |
Maureen Hart | Stephen Bassett | Heather Smith |
Axcelis Technologies, Inc. | Axcelis Technologies, Inc. | Loomis Group |
Tel: +1 (978) 787 4266 | Tel: +1 (978) 787 4000 | Tel: +1 (617) 638 0022 |
Fax: +1 (978) 787 4275 | Fax: +1 (978) 787 9133 | Fax: +1 (617) 638 0033 |
maureen.hart@axcelis.com | investor.relations@axcelis.com | smithh@loomisgroup.com |
AXCELIS ANNOUNCES FINANCIAL RESULTS FOR
THE THIRD QUARTER OF 2006
Reports Strong Traction for Optima Single Wafer Implant Technology
and Continued Demand for Dry Strip Products
BEVERLY, Mass. — November 1, 2006 — Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for its third quarter ended September 30, 2006. The Company reported revenues of $122.8 million, compared to $117.6 million for the second quarter of 2006. Worldwide revenues for the third quarter, which include revenues of SEN Corporation, an SHI and Axcelis Company, the Company’s 50%-owned joint venture in Japan, were $168.1 million, compared to $198.2 million for the preceding quarter. Net income for the third quarter was $12.5 million, or $0.12 per share, compared to net income for the second quarter of 2006 of $12.1 million, or $0.12 per share. In the corresponding quarter for the previous year, the Company reported net revenues of $87.4 million, worldwide revenues of $126.3 million, and net loss of $5.2 million, or $0.05 per share, which included restructuring and related costs of $2.9 million, or $0.03 per diluted share.
Commenting on the Company’s performance, Chairman and CEO Mary Puma said, “During the quarter, we achieved financial results in line with our expectations, and we continue to execute successfully against our business plan. Since June 30th, we have secured four new penetrations for our single wafer Optima HD high dose system. Two of these systems feature Axcelis’ new ImaxTM technology, which delivers the power of molecular implants for low energy applications. This new product offering is gaining traction with customers because it delivers compelling productivity and yield advantages, enabling state-of-the-art device manufacturing.”
Puma continued, “Our dry strip products are in high demand, as customers continue to add capacity. Overall, the dry strip product line is having a very good year, achieving significant market share gains and providing strong value to our business model.”
Axcelis believes that reporting the combined revenues of SEN, a 50%-owned unconsolidated subsidiary of Axcelis, with Axcelis’ own revenues, is useful to investors. SEN’s ion implant products are covered by a license from Axcelis, and therefore the combined revenue of the two companies indicates the full market penetration of Axcelis’ technology.
Third Quarter Detail
Shipments and Margins
Shipments before provision for deferred revenue for the third quarter totaled $128.1 million with worldwide shipments, including SEN, totaling $205.4 million. This compares to Axcelis shipments, excluding SEN, of $116.6 million in the second quarter of 2006 and worldwide shipments, including SEN, of $195.7 million.
Geographically, Axcelis systems shipments, excluding SEN, were to: Asia, 49%; North America, 20%; and Europe, 31%.
The ion implantation business (excluding SEN) accounted for 73% of total shipments in the third quarter while other products (RTP, Dry Strip and Curing) accounted for 27%.
Service revenue (service labor, spare parts and consumables), excluding SEN, was $42.1 million for the quarter, compared to $46.9 million in the second quarter of 2006.
Gross margin for the third quarter was 43.4%, up from 40.8% in the preceding quarter.
Orders and Backlog
Orders (new systems bookings and service excluding SEN) received for the third quarter totaled $101.0 million, compared to $159.1 million for the second quarter of 2006. New system bookings, excluding service, amounted to $59.0 million compared to $112.2 million for the preceding quarter. Worldwide orders, including SEN, were $164.1 million, compared to $260.3 million for the second quarter of 2006.
Backlog plus deferred systems revenue at quarter end was $107.8 million. Backlog consists of systems only (i.e., excluding service contracts) that are generally scheduled to ship within six months.
Balance Sheet
Cash, cash equivalents and marketable securities increased by $17.6 million to $193.8 million at September 30, 2006. The Company ended the quarter with working capital of $277.6 million.
Business Outlook
Axcelis’ financial outlook for the fourth quarter of 2006 includes revenues in the range of $115.0 million to $125.0 million. Worldwide revenues, including SEN, are expected to be in a range of $230.0 million to $245.0 million. As expected, the Company anticipates lower gross margins in the fourth quarter in the range of 38% to 40%, as a result of revenue recognition on new products. The Company forecasts earnings per share in the range of $0.11 to $0.15 per share.
Stephen Bassett, Axcelis executive vice president and CFO, commented, “As expected, our fourth quarter margins are under pressure due to several new products in the mix. Taking into account our fourth quarter guidance and performance year-to-date, Axcelis will outperform our expectations for the year, as shared with investors in our February 2006 earnings call. At that time, we expected
a revenue increase of 15-20% year over year, while maintaining overall margins of 40%. We continue to execute to our business plan, positioning us for significant market share growth and improved profitability in 2007.”
Axcelis assumes no responsibility to update guidance. Axcelis will only confirm or update guidance via a press release.
Third Quarter 2006 Conference Call
The Company will be hosting a conference call today, Wednesday, November 1, 2006, beginning at 5:00 pm ET. The purpose of the call is to discuss third quarter results and to provide guidance for the fourth quarter of 2006.
The call will be available to interested listeners via an audio webcast that can be accessed through Axcelis’ home page at www.axcelis.com, or by dialing 1-800-479-1628 (1-719-457-2729 outside North America). Participants calling into the conference call will be requested to provide the company name: Axcelis Technologies, the conference leader: Maureen Hart, and pass code: #1342692. A webcast replay will be available from 8:00 pm ET on November 1, 2006 until 5:00 pm ET December 1, 2006.
Safe Harbor Statement
This document contains forward-looking statements under the SEC safe harbor provisions. These statements, which include those relating to the company developing new products, building its position in the ion implant market, and its guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties, many of which are outside the control of the Company, including the timing of orders and shipments, the conversion of orders to revenue in any particular quarter, or at all, our ability to implement successfully our profit plans, the continuing demand for semiconductor equipment, relative market growth, continuity of business relationships with and purchases by major customers, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.
About Axcelis Technologies, Inc.
Axcelis Technologies, Inc., headquartered in Beverly, Massachusetts, provides innovative, high-productivity solutions for the semiconductor industry. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation, rapid thermal processing, and cleaning and curing systems. Axcelis Technologies has key product development centers in Beverly, Massachusetts, as well as in Saijo, Japan through its joint venture, SEN Corporation, an SHI and Axcelis Company. The company’s Internet address is: www.axcelis.com.
